# Sionna Therapeutics, Inc.: Form 8-K, filed Jun 4, 2025

- Company: [Sionna Therapeutics, Inc.](/companies/sion.md) (CIK 2036042)
- Form: 8-K
- Filed: 2025-06-04
- Accepted by EDGAR: Jun 4, 2025, 07:13 ET
- Period: 2025-06-04
- Accession: 0001193125-25-134462
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/2036042/000119312525134462/d944102d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/2036042/000119312525134462/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/2036042/000119312525134462/d944102d8k.htm

Filed Jun 4, 2025.
Source: SEC EDGAR, the filing index for accession 0001193125-25-134462. Last ingested by Listed: Nov 10, 2026, 16:50 ET. No prices; not investment advice.
